Snyder M - Search Results

1

Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility.

Tolan NV, DeSimone MS, Fernandes MD, Lewis JE, Simmons DP, Schur PH, Brigl M, Tanasijevic MJ, Desjardins M, Sherman AC, Baden LR, Snyder M, Melanson SE. Tolan NV, et al. Among authors: snyder m. Clin Biochem. 2023 Jul;117:60-68. doi: 10.1016/j.clinbiochem.2023.03.003. Epub 2023 Mar 5. Clin Biochem. 2023. PMID: 36878344 Free PMC article.

2

A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl compliance.

Snyder ML, Jarolim P, Melanson SE. Snyder ML, et al. Clin Chim Acta. 2011 May 12;412(11-12):946-51. doi: 10.1016/j.cca.2011.01.029. Epub 2011 Jan 31. Clin Chim Acta. 2011. PMID: 21281622

3

A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse.

Melanson SE, Snyder ML, Jarolim P, Flood JG. Melanson SE, et al. J Anal Toxicol. 2012 Apr;36(3):201-6. doi: 10.1093/jat/bks003. J Anal Toxicol. 2012. PMID: 22417836

4

Significant cost savings achieved by in-sourcing urine drug testing for monitoring medication compliance in pain management.

Melanson SE, Tanasijevic MJ, Snyder ML, Darragh A, Quade C, Jarolim P. Melanson SE, et al. Clin Chim Acta. 2013 Jun 25;422:10-4. doi: 10.1016/j.cca.2013.03.010. Epub 2013 Mar 29. Clin Chim Acta. 2013. PMID: 23545276

5

Improved buprenorphine immunoassay performance after urine treatment with β-glucuronidase.

Snyder ML, Darragh A, Flood JG, Jones J, Ropar K, Jarolim P, Melanson SE. Snyder ML, et al. J Anal Toxicol. 2014 Jul-Aug;38(6):375-9. doi: 10.1093/jat/bku045. Epub 2014 May 6. J Anal Toxicol. 2014. PMID: 24802159

6

KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.

Darragh A, Snyder ML, Ptolemy AS, Melanson S. Darragh A, et al. Pain Physician. 2014 Jul-Aug;17(4):359-66. Pain Physician. 2014. PMID: 25054395 Free article.

7

Drug addiction or false conviction?

Snyder ML, Melanson SE. Snyder ML, et al. Clin Chem. 2014 Dec;60(12):1480-3. doi: 10.1373/clinchem.2013.216861. Clin Chem. 2014. PMID: 25432992 No abstract available.

8

Immunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic Pain.

Snyder ML, Fantz CR, Melanson S. Snyder ML, et al. Pain Physician. 2017 Feb;20(2S):SE1-SE9. Pain Physician. 2017. PMID: 28226337 Free article.

9

Despite the improved clinical sensitivity of the Roche benzodiazepines II assay it cannot replace mass spectrometry in all patient populations.

Tolan NV, Uljon S, Lauren Donnelly-Morell M, Zhao M, Mahowald GK, Snyder ML, Contella L, Urwiller ED, Daluz Fernandes M, Kang P, Melanson SEF. Tolan NV, et al. Among authors: snyder ml. J Mass Spectrom Adv Clin Lab. 2024 Jun 25;33:14-20. doi: 10.1016/j.jmsacl.2024.06.002. eCollection 2024 Aug. J Mass Spectrom Adv Clin Lab. 2024. PMID: 39041051 Free PMC article.

10

Clinical performance of a new lateral flow immunoassay for xylazine detection.

Contella L, Snyder ML, Kang P, Tolan NV, Melanson SEF. Contella L, et al. Clin Chem Lab Med. 2024 Oct 14. doi: 10.1515/cclm-2024-0947. Online ahead of print. Clin Chem Lab Med. 2024. PMID: 39392655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,379 results

Search Page

Filters